NeuBase Therapeutics Inc (NAS:NBSE)
$ 0.4101 0.0051 (1.26%) Market Cap: 1.54 Mil Enterprise Value: -5.72 Mil PE Ratio: 0 PB Ratio: 0.17 GF Score: 33/100